![](https://www.businessmarketinsights.com/assets/img/reports-icon.png)
南美洲病毒学市场预测至 2028 年 - COVID-19 影响和按类型(诊断测试、病毒感染控制技术、抗病毒治疗和干扰素)、应用(皮肤和软组织感染、呼吸道感染、胃肠道感染、性)的区域分析传染病、尿路感染等)和最终用户(医院、诊断实验室、制药和生物技术公司以及研究和学术机构)
市场介绍
南美洲(SAM)地区由巴西、阿根廷和南美洲其他地区组成。病毒学市场的增长可归因于私人和公共组织不断增加的研发投资。此外,艾滋病毒、肝炎和病毒感染发病率的增加正在推动未来几年各种治疗方法的采用。由于医疗保健支出增加,巴西在医疗保健领域取得了巨大进步。根据国际贸易管理局 (ITA) 的数据,巴西是拉丁美洲最大的医疗保健市场,其 GDP 的 9.1% 用于医疗保健。巴西目前正面临最大的公共卫生危机之一。此外,此前寨卡病毒(ZIKV)引起的疫情在巴西并存,增加了卫生部门的负担。寨卡病毒感染于 2015 年在巴西爆发。2019 年,巴西共发现 10,768 例寨卡病毒感染病例,2020 年,该国卫生系统受到 COVID-19 的严重打击。最近的病毒爆发为传染病研究的更多投资铺平了道路,进一步推动了病毒学市场的发展。此外,巴西艾滋病毒和艾滋病疫情稳定,总人口患病率为0.5%。根据 Avert Organization 的数据,2019 年,约有 92 万人感染艾滋病毒,并记录了约 48,000 例新感染病例。该国针对艾滋病毒流行采取了许多措施,推动了病毒学市场的发展。例如,2017 年,巴西开始向 10 万人提供多替拉韦 (DTG)。因此,医疗保健支出的增加和新疗法的采用推动了预测期内的市场增长。病毒传染病流行率的上升是推动 SAM 病毒学市场增长的主要因素。
COVID-19 造成了冲击波,带来了严重的健康、经济和社会后果,这将影响南方许多国家未来的美国。 COVID-19大流行带来了重大疾病暴发的风险,凸显了各国的应对之策。缺乏与他们战斗的准备。气候变化、城市化以及缺乏水和卫生设施正在导致疫情迅速蔓延。在 COVID-19 爆发之前,阿根廷的社会经济形势就已经处于脆弱的状态。根据国家统计和普查局 (INDEC) 的数据,2020 年 5 月经济活动下降了 10.3%,而 2020 年 6 月年通胀率达到 42.8%。其中许多国家的卫生系统脆弱,融资或驱动手段有限。疫苗的开发本身也使大量人口面临更高的风险。 COVID-19 大流行扰乱了整个南美洲的医疗保健服务。例如,在危地马拉,COVID-19 严重影响了艾滋病毒服务; 2020 年,艾滋病毒检测量下降了 54.7%。根据泛美卫生组织的数据,自疫情爆发以来,拉丁美洲接受艾滋病毒检测的人数急剧下降。 COVID-19 预计将加剧这种情况,特别是在卫生系统脆弱的国家。
市场概况和动态
SAM 的病毒学市场预计将从 2021 年的 2.5448 亿美元增长到 2028 年的 3.1427 亿美元;预计 2021 年至 2028 年复合年增长率为 3.1%。阿根廷和智利等国家对该地区的制药和生物制药行业来说是有吸引力的外包地点。阿根廷和智利的低制造和运营成本以及近期制药业的增长是推动这些国家病毒学相关市场增长的关键因素。此外,不断增长的国内市场及其管道正在为该地区的仿制药生产开辟新的途径。此外,一些合同组织正在扩大其在欧洲国家的制造能力,以满足对疫苗等产品不断增长的需求。因此,新兴市场可能会在未来几年为整个 SAM 地区病毒学市场的增长创造利润丰厚的机会。
关键细分市场
SAM 病毒学市场根据类型、应用、最终用户和国家/地区进行细分。根据类型,市场分为诊断测试、病毒感染控制技术、抗病毒治疗和干扰素。抗病毒治疗领域在 2020 年占据市场主导地位,病毒感染控制技术领域预计将在预测期内增长最快。诊断测试部分进一步分为DNA病毒测试、RNA病毒测试等。同样,病毒感染控制技术分为主动预防和被动预防。同样,抗病毒治疗分为杀病毒剂、抗病毒剂、免疫调节剂和干扰素。根据应用,病毒学市场分为皮肤和软组织感染、呼吸道感染、胃肠道感染、性传播疾病、尿路感染等。呼吸道感染领域在 2020 年占据市场主导地位,预计将在预测期内增长最快。根据最终用户,病毒学市场分为医院、诊断实验室、制药和生物技术公司以及研究和学术机构。医院细分市场在 2020 年占据市场主导地位,诊断实验室细分市场预计将在预测期内增长最快。
主要来源和上市公司
准备本 SAM 病毒学市场报告时参考的一些主要一手和二手来源包括公司网站、年度报告、财务报告、国家政府文件和统计数据库等。报告中列出的主要公司有雅培(Abbott);艾伯维公司; F.霍夫曼-拉罗氏有限公司;吉利德科学公司;葛兰素史克公司;照明公司;强生服务公司;凯杰;西门子公司;和 Thermo Fisher Scientific Inc. 等。
购买报告的理由
- 了解 SAM 病毒学市场格局并确定最有可能保证强劲回报的细分市场
- 通过理解SAM 病毒学市场不断变化的竞争格局
- 通过识别最有可能销售前景的细分市场,有效规划 SAM 病毒学市场的并购和合作交易
- 帮助通过对 SAM 病毒学市场各个细分市场的市场表现进行敏锐和全面的分析,做出明智的业务决策
- 获取 SAM 地区 2021-2028 年各个细分市场的市场收入预测。
SAM 病毒学市场细分
SAM 病毒学市场 - 按类型
- 诊断检测
- DNA病毒检测
- RNA病毒检测
- 其他
- 病毒感染控制技术
- 主动预防
- 被动预防
- 抗病毒治疗
- 杀病毒剂
- 抗病毒剂
- 免疫调节剂
- 干扰素
SAM病毒学市场 - 按应用
- 皮肤和软组织感染
- 呼吸道肠道感染
- 胃肠道感染
- 性传播疾病
- 尿路感染
- 其他
SAM 病毒学市场 - 按最终用户
- 医院
- 诊断实验室
- 制药和生物技术公司
- 研究和学术机构
SAM 病毒学市场 - 按国家/地区
< ul>SAM 病毒学市场 -公司简介
- 雅培
- AbbVie Inc.
- F. Hoffmann-La Roche Ltd.
- 吉利德科学公司
- 葛兰素史克公司
- Illumina, Inc.
- 强生服务公司, Inc.
- QIAGEN
- 西门子股份公司
- Thermo Fisher Scientific Inc.
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 SAM Virology Market – By Type
1.3.2 SAM Virology Market – By Application
1.3.3 SAM Virology Market – By End User
1.3.4 SAM Virology Market– By Country
2. SAM Virology Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. SAM Virology Market– Market Landscape
4.1 Overview
4.2 SAM PEST Analysis
4.3 Experts Opinion
5. SAM Virology Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Prevalence of Viral Infectious Diseases
5.1.2 Surging Product Launches
5.2 Market Restraints
5.2.1 Availability of Alternative Products and High Cost of Production of Products
5.3 Market Opportunities
5.3.1 Immense Growth Potential in Emerging Economies
5.4 Future Trends
5.4.1 Continuous Demand for Cost-Effective Products
5.5 Impact Analysis
6. Virology Market– SAM Analysis
6.1 SAM Virology Market Revenue Forecast and Analysis
7. SAM Virology Market Analysis – By Type
7.1 Overview
7.2 SAM Virology Market Revenue Share, by Type (2021 and 2028)
7.3 Diagnostic Test
7.3.1 Overview
7.3.2 Diagnostic Test: Virology Market – Revenue and Forecast to 2028 (US$ Million)
7.3.2.1 Deoxyribonucleic Acid (DNA) Virus Testing
7.3.2.1.1 Overview
7.3.2.1.2 DNA Virus Testing: Virology Market – Revenue and Forecast to 2028 (US$ Million)
7.3.2.2 Ribonucleic Acid (RNA) Virus Testing
7.3.2.2.1 Overview
7.3.2.2.2 RNA Virus Testing: Virology Market – Revenue and Forecast to 2028 (US$ Million)
7.3.2.3 Others
7.3.2.3.1 Overview
7.3.2.3.2 Others: Virology Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Viral Infection Controlling Techniques
7.4.1 Overview
7.4.2 Viral Infection Controlling Techniques: Virology Market – Revenue and Forecast to 2028 (US$ Million)
7.4.2.1 Active Prophylaxis
7.4.2.1.1 Overview
7.4.2.1.2 Active Prophylaxis: Virology Market – Revenue and Forecast to 2028 (US$ Million)
7.4.2.2 Passive Prophylaxis
7.4.2.2.1 Overview
7.4.2.2.2 Passive Prophylaxis: Virology Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Antiviral Therapeutics
7.5.1 Overview
7.5.2 Antiviral Therapeutics: Virology Market – Revenue and Forecast to 2028 (US$ Million)
7.5.2.1 Virucidal Agents
7.5.2.1.1 Overview
7.5.2.1.2 Virucidal Agents: Virology Market – Revenue and Forecast to 2028 (US$ Million)
7.5.2.2 Antiviral Agents
7.5.2.2.1 Overview
7.5.2.2.2 Antiviral Agents: Virology Market – Revenue and Forecast to 2028 (US$ Million)
7.5.2.3 Immunomodulators
7.5.2.3.1 Overview
7.5.2.3.2 Immunomodulators: Virology Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Interferons
7.6.1 Overview
7.6.2 Interferons: Virology Market – Revenue and Forecast to 2028 (US$ Million)
8. SAM Virology Market Analysis – By Application
8.1 Overview
8.2 SAM Virology Market, by Application 2021 & 2028 (%)
8.3 Skin and Soft Tissue Infections
8.3.1 Overview
8.3.2 Skin and Soft Tissue Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Respiratory Tract Infections
8.4.1 Overview
8.4.2 Respiratory Tract Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)
8.5 GI Tract Infections
8.5.1 Overview
8.5.2 GI Tract Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Sexually Transmitted Diseases
8.6.1 Overview
8.6.2 Sexually Transmitted Diseases: Virology Market – Revenue and Forecast to 2028 (US$ Million)
8.7 Urinary Tract Infections
8.7.1 Overview
8.7.2 Urinary Tract Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)
8.8 Others
8.8.1 Overview
8.8.2 Others: Virology Market – Revenue and Forecast to 2028 (US$ Million)
9. SAM Virology Market Analysis – By End User
9.1 Overview
9.2 SAM Virology Market Revenue Share, by End User (2021 and 2028)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: Virology Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Diagnostic Laboratories
9.4.1 Overview
9.4.2 Diagnostic Laboratories: Virology Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Pharmaceutical and Biotechnological Companies
9.5.1 Overview
9.5.2 Pharmaceutical and Biotechnological Companies: Virology Market – Revenue and Forecast to 2028 (US$ Million)
9.6 Research and Academic Institutes
9.6.1 Overview
9.6.2 Research and Academic Institutes: Virology Market – Revenue and Forecast to 2028 (US$ Million)
10. SAM Virology Market – Country Analysis
10.1.1 Overview
10.1.2 South America: Virology Market, by Country, 2021 & 2028 (%)
10.1.2.1 Brazil: Virology Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.1.1 Brazil: Virology Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.1.2 Brazil: Virology Market, By Type, 2019–2028 (USD Million)
10.1.2.1.2.1 Brazil: Virology Market, by Diagnostic Test, 2019–2028 (USD Million)
10.1.2.1.2.2 Brazil: Virology Market, by Viral Infection Controlling Techniques, 2019–2028 (USD Million)
10.1.2.1.2.3 Brazil: Virology Market, by Antiviral Therapeutics, 2019–2028 (USD Million)
10.1.2.1.3 Brazil: Virology Market, by Application, 2019–2028 (USD Million)
10.1.2.1.4 Brazil: Virology Market, by End User, 2019–2028 (USD Million)
10.1.2.2 Argentina: Virology Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.2.1 Argentina: Virology Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.2.2 Argentina: Virology Market, By Type, 2019–2028 (USD Million)
10.1.2.2.2.1 Argentina: Virology Market, by Diagnostic Test, 2019–2028 (USD Million)
10.1.2.2.2.2 Argentina: Virology Market, by Viral Infection Controlling Techniques, 2019–2028 (USD Million)
10.1.2.2.2.3 Argentina: Virology Market, by Antiviral Therapeutics, 2019–2028 (USD Million)
10.1.2.2.3 Argentina: Virology Market, by Application, 2019–2028 (USD Million)
10.1.2.2.4 Argentina: Virology Market, by End User, 2019–2028 (USD Million)
10.1.2.3 Rest of South America: Virology Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.3.1 Rest of South America: Virology Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.3.2 Rest of South America: Virology Market, By Type, 2019–2028 (USD Million)
10.1.2.3.2.1 Rest of South America: Virology Market, by Diagnostic Test, 2019–2028 (USD Million)
10.1.2.3.2.2 Rest of South America: Virology Market, by Viral Infection Controlling Techniques, 2019–2028 (USD Million)
10.1.2.3.2.3 Rest of South America: Virology Market, by Antiviral Therapeutics, 2019–2028 (USD Million)
10.1.2.3.3 Rest of South America: Virology Market, by Application, 2019–2028 (USD Million)
10.1.2.3.4 Rest of South America: Virology Market, by End User, 2019–2028 (USD Million)
11. Impact of COVID-19 Pandemic on SAM Virology Market
11.1 Overview
12. SAM Virology Market–Industry Landscape
12.1 Overview
12.2 Organic Developments
12.2.1 Overview
12.3 Inorganic Developments
12.3.1 Overview
13. Company Profiles
13.1 Abbott
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Johnson and Johnson Services, Inc.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 F. HOFFMANN-LA ROCHE LTD.
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 THERMO FISHER SCIENTIFIC INC.
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 QIAGEN
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Illumina, Inc.
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Siemens AG
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 GlaxoSmithKline Plc
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 AbbVie Inc.
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Gilead Sciences, Inc.
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. SAM Virology Market Revenue and Forecast to 2028 (US$ Million)
Table 2. Brazil: Virology Market, By Type – Revenue and Forecast to 2028 (USD Million)
Table 3. Brazil Virology Market, by Diagnostic Test– Revenue and Forecast to 2028 (USD Million)
Table 4. Brazil Virology Market, by Viral Infection Controlling Techniques– Revenue and Forecast to 2028 (USD Million)
Table 5. Brazil Virology Market, by Antiviral Therapeutics– Revenue and Forecast to 2028 (USD Million)
Table 6. Brazil: Virology Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 7. Brazil: Virology Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 8. Argentina: Virology Market, By Type – Revenue and Forecast to 2028 (USD Million)
Table 9. Argentina Virology Market, by Diagnostic Test– Revenue and Forecast to 2028 (USD Million)
Table 10. Argentina Virology Market, by Viral Infection Controlling Techniques– Revenue and Forecast to 2028 (USD Million)
Table 11. Argentina Virology Market, by Antiviral Therapeutics– Revenue and Forecast to 2028 (USD Million)
Table 12. Argentina: Virology Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 13. Argentina: Virology Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 14. Rest of South America: Virology Market, By Type – Revenue and Forecast to 2028 (USD Million)
Table 15. Rest of South America Virology Market, by Diagnostic Test– Revenue and Forecast to 2028 (USD Million)
Table 16. Rest of South America Virology Market, by Viral Infection Controlling Techniques– Revenue and Forecast to 2028 (USD Million
Table 17. Rest of South America Virology Market, by Antiviral Therapeutics– Revenue and Forecast to 2028 (USD Million)
Table 18. Rest of South America: Virology Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 19. Rest of South America: Virology Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 20. Organic Developments Done by Companies
Table 21. Inorganic Developments Done by Companies
Table 22. Glossary of Terms, SAM Virology Market
LIST OF FIGURES
Figure 1. SAM Virology Market Segmentation
Figure 2. SAM Virology Segmentation, By Country
Figure 3. SAM Virology Market Overview
Figure 4. Antiviral Therapeutics Held the Largest Share of the Type Segment in SAM Virology Market
Figure 5. Respiratory Tract Infections Held the Largest Share of the Application Segment in SAM Virology Market
Figure 6. Brazil to Show Significant Growth During Forecast Period
Figure 7. SAM PEST Analysis
Figure 8. SAM Virology Market: Impact Analysis of Drivers and Restraints
Figure 9. SAM Virology Market– Revenue Forecast and Analysis – 2019- 2028
Figure 10. SAM Virology Market Revenue Share, by Type (2021 and 2028)
Figure 11. SAM Diagnostic Test: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. SAM DNA Virus Testing: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. SAM RNA Virus Testing: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. SAM Others: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. SAM Viral Infection Controlling Techniques: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. SAM Active Prophylaxis: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. SAM Passive Prophylaxis: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. SAM Antiviral Therapeutics: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. SAM Virucidal Agents: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. SAM Antiviral Agents: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. SAM Immunomodulators: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. SAM Interferons: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. SAM Virology Market, by Application 2021 & 2028 (%)
Figure 24. SAM Skin and Soft Tissue Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. SAM Respiratory Tract Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. SAM GI Tract Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. SAM Sexually Transmitted Diseases: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. SAM Urinary Tract Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. SAM Others: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 30. SAM Virology Market Revenue Share, by End User (2021 and 2028)
Figure 31. SAM Hospitals: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 32. SAM Diagnostic Laboratories: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 33. SAM Pharmaceutical and Biotechnological Companies: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 34. SAM Research and Academic Institutes: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 35. South America: Virology Market, by Key Country – Revenue (2021) (USD Million)
Figure 36. South America: Virology Market, by Country, 2021 & 2028 (%)
Figure 37. Brazil: Virology Market – Revenue and Forecast to 2028 (USD Million)
Figure 38. Argentina: Virology Market – Revenue and Forecast to 2028 (USD Million)
Figure 39. Rest of South America: Virology Market – Revenue and Forecast to 2028 (USD Million)
Figure 40. Impact of COVID-19 Pandemic on Virology Market in SAM Countries
- Abbott
- AbbVie Inc.
- F. Hoffmann-La Roche Ltd.
- Gilead Sciences, Inc.
- GlaxoSmithKline Plc
- Illumina, Inc.
- Johnson and Johnson Services, Inc.
- QIAGEN
- Siemens AG
- Thermo Fisher Scientific Inc.
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the SAM Virology market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the SAM Virology market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth SAM market trends and outlook coupled with the factors driving the Virology market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution